JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
CALL
Parker-Hannifin
PH
$134B
| $2.99M | ﹤0.01% |
15,000
-25,000
| -63% | -$4.65M |
|
2927
CALL
Capital One
COF
$137B
| $2.99M | ﹤0.01% |
30,000
| – | – |
|
|
2928
PUT
Capital One
COF
$137B
| $2.99M | ﹤0.01% |
30,000
-46,700
| -61% | -$4.26M |
|
2929
LivePerson
LPSN
$35.9M
| $2.98M | ﹤0.01% |
17,286
+12,250
| +243% | +$2.29M |
|
2930
PUT
Vertex Pharmaceuticals
VRTX
$131B
| $2.98M | ﹤0.01% |
19,900
-188,600
| -90% | -$27.9M |
|
2931
CALL
Travelers Companies
TRV
$77.2B
| $2.97M | ﹤0.01% |
21,900
-32,700
| -60% | -$4.32M |
|
2932
CALL
Sociedad Química y Minera de Chile
SQM
$20.6B
| $2.97M | ﹤0.01% |
+50,000
| New | +$2.87M |
|
2933
X4 Pharmaceuticals
XFOR
$425M
| $2.97M | ﹤0.01% |
+1,292
| New | +$3.27M |
|
|
AY
2934
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.97M | ﹤0.01% |
139,845
+17,451
| +14% | +$381K |
|
|
TSC
2935
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.97M | ﹤0.01% |
128,942
-117,883
| -48% | -$2.74M |
|
|
ESPR
2936
CALL
DELISTED
Esperion Therapeutics
ESPR
| $2.96M | ﹤0.01% |
+45,000
| New | +$2.42M |
|
|
ESPR
2937
PUT
DELISTED
Esperion Therapeutics
ESPR
| $2.96M | ﹤0.01% |
+45,000
| New | +$2.42M |
|
|
CORE
2938
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.96M | ﹤0.01% |
93,642
+4,339
| +5% | +$139K |
|
2939
iShares US Home Construction ETF
ITB
$2.37B
| $2.95M | ﹤0.01% |
67,476
-3,281
| -5% | -$133K |
|
2940
CALL
Carnival Corporation Ltd
CCL
$38.9B
| $2.95M | ﹤0.01% |
44,400
| – | – |
|
|
2941
PUT
Carnival Corporation Ltd
CCL
$38.9B
| $2.95M | ﹤0.01% |
44,400
| – | – |
|
|
AFAM
2942
DELISTED
Almost Family Inc
AFAM
| $2.94M | ﹤0.01% |
53,184
+52,589
| +8,838% | +$2.8M |
|
|
BRG
2943
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $2.94M | ﹤0.01% |
290,856
-35,044
| -11% | -$389K |
|
|
UBNK
2944
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.94M | ﹤0.01% |
166,619
+4,394
| +3% | +$80K |
|
2945
Fossil Group
FOSL
$330M
| $2.93M | ﹤0.01% |
377,506
-7,098
| -2% | -$55K |
|
2946
CALL
Aflac
AFL
$60.7B
| $2.93M | ﹤0.01% |
66,800
+40,000
| +149% | +$1.71M |
|
|
GWR
2947
DELISTED
Genesee & Wyoming Inc.
GWR
| $2.93M | ﹤0.01% |
37,211
+22,497
| +153% | +$1.68M |
|
2948
CALL
MBIA
MBI
$262M
| $2.93M | ﹤0.01% |
400,000
| – | – |
|
2949
Argan
AGX
$7.84B
| $2.93M | ﹤0.01% |
65,054
+4,720
| +8% | +$281K |
|
2950
ESCO Technologies
ESE
$7.79B
| $2.93M | ﹤0.01% |
48,591
+32,693
| +206% | +$1.99M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.